GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
Synonyms: AMC-109 | LTX 109 | LTX-109 | Lytixar®
Compound class:
Synthetic organic
Comment: Voxvoganan is the clinical lead from a series of synthetic antimicrobial peptidomimetics (SAMPs) with Gram-positive and Gram-negative antibacterial activity [1-2].
|
|
Classification ![]() |
|
Compound class | Synthetic organic |
International Nonproprietary Names ![]() |
|
INN number | INN |
12025 | voxvoganan |
Synonyms ![]() |
AMC-109 | LTX 109 | LTX-109 | Lytixar® |
Database Links ![]() |
|
Specialist databases | |
Antibiotic DB
![]() |
LTX-109 |
Other databases | |
CAS Registry No. | 1166254-80-3 (source: Scifinder) |
ChEBI | CHEBI:77752 |
ChEMBL Ligand | CHEMBL1817968 |
DrugBank Ligand | DB12711 |
GtoPdb PubChem SID | 507750392 |
PubChem CID | 25242323 |
Search Google for chemical match using the InChIKey | ZVOYWSKEBVVLGW-ZDCRTTOTSA-N |
Search Google for chemicals with the same backbone | ZVOYWSKEBVVLGW |
Search PubMed clinical trials | voxvoganan |
Search PubMed titles | voxvoganan |
Search PubMed titles/abstracts | voxvoganan |
UniChem Compound Search for chemical match using the InChIKey | ZVOYWSKEBVVLGW-ZDCRTTOTSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | ZVOYWSKEBVVLGW-ZDCRTTOTSA-N |